Searching...Lobbying Arrangements: Pharmacy
New Lobbying Registrations About Pharmacy By Quarter
Former Covered Federal Workers:
Other Lobbyists:
| Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
|---|---|---|---|---|---|
| Details ACA coverage for all adult vaccines (regulation related to Public Health Service Act, Sec 2713); Appropriations related to CDC report on arbovirus threat; Appropriations related to funding the Stat... |
VALNEVA USA, INC.
|
in-house lobbying | |||
| Details Issues related to implementation of the drug pricing provisions of the Inflation Reduction Act of 2022. S.142 - Preserve Access to Affordable Generics and Biosimilars Act - in support S.150 - Affo... |
New Venture Fund
|
PORT SIDE STRATEGIES, LLC | |||
| Details Issues related to government involvement in the development of COVID-19 therapies |
Pardes Biosciences, Inc.
|
RICCHETTI INCORPORATED | |||
| Details Funding for oral antivirals for covid. Physician prescribing of covid antivirals Medicare coverage of oral antivirals NIH funding for clinical trials |
Pardes Biosciences, Inc.
|
in-house lobbying | |||
| Details Issues related to overdose reversal products; H.R.2617, Consolidated Appropriations Act, 2023 (P.L.117-328) implementation; FY2024 Departments of Labor, Health and Human Services, and Education, an... |
Indivior Inc.
|
Crossroads Strategies, LLC | |||
| Details Strategy development and implementation of federal government relations initiatives relating to phospholine iodide issues with the Food and Drug Administration and Centers for Medicare and Medicaid... |
Fera Pharmaceuticals, LLC
|
BUCHANAN INGERSOLL & ROONEY PC | |||
| Details Federal Trade Commission - antitrust issues related to PBMs FTC inquiry into competitive market for PBMs |
The Pharmaceutical Care Management Association
|
Bose Public Affairs Group | |||
| Details Federal Trade Commission - antitrust issues related to PBMs FTC inquiry into competitive market for PBMs |
The Pharmaceutical Care Management Association
|
Bose Public Affairs Group | |||
| Details Introduction to Prime to new Members of the 118th Congress Monitoring PBM Legislation Senate Finance Committee PBM Framework - Delinking S.1339 - The Pharmacy Benefit Manager Reform - Delinking H.R... |
Prime Therapeutics
|
STUMPTOWN STRATEGIES | |||
| Details Federal contracts for biopharmaceuticals development. |
SAb Biotherapeutics, Inc.
|
DLA Piper LLP (US) | |||
| Details Issues related to higher education, entrepreneurship and innovation center, emergency preparedness, accessibility issues, and appropriations. |
The University of Louisiana Monroe Foundation
|
Cornerstone Government Affairs, Inc. | |||
| Details Safe step act, help copays act, chronic disease education and awareness program at CDC. CDC chronic disease education and awareness program - appropriations! Inflation Reduction Act and Part D out ... |
NATIONAL PSORIASIS FOUNDATION
|
in-house lobbying | |||
| Details Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies |
Jazz Pharmaceuticals, Inc.
|
in-house lobbying | |||
| Details Federal Trade Commission - antitrust issues related to PBMs FTC inquiry into competitive market for PBMs |
The Pharmaceutical Care Management Association
|
Bose Public Affairs Group | |||
| Details Advising on issues related to healthcare and sustainability |
AstraZeneca Pharmaceuticals LP
|
PRIME POLICY GROUP | |||
| Details supply chain & FDA issues |
Exela Pharma Sciences, LLC
|
Old North Strategies, LLC | |||
| Details Budget, housing, mental health |
NAMI OHIO
|
McCaulley&Company | |||
| Details Drug safety. |
Verde Environmental Technologies, Inc.
|
Faegre Drinker Biddle & Reath LLP | |||
| Details Issues related to healthcare consumerism and pharmacy transparency. FY24 Financial Services and General Government Appropriations Act, H.R.4664/S.2309, issues related to CMS, Federal Employee Healt... |
Rx Savings, LLC dba Rx Savings Solutions
|
Venture Government Strategies, LLC (fka Hobart Hallaway & Quayle Ventures, LLC) | |||
| Details DoD/PRMRP Appropriation, Labor Health and Human Services Appropriations DoD PRMRP Appropriaiton DoD & Labor H&HS Appropriations |
SomaLogic Operating Co., Inc.
|
Virtual Operations, LLC | |||
| Details Issues related to Medicare Part D plans. |
National Association of Chain Drug Stores
|
Mr. Kevin Kayes | |||
| Details Rare kidney disease Orphan Drug Act Orphan drug act |
Travere Therapeutics
|
2359 STRATEGIES | |||
| Details rare kidney disease Rare kidney disease |
Travere Therapeutics
|
THE HEALTH EQUITY STRATEGIES GROUP, LLC | |||
| Details Issues related to the disease of diabetes, diabetes therapies and management of the disease of diabetes. Issues related to medical devices and medical device technology. Issues related to medical ... |
Insulet Corporation
|
in-house lobbying | |||
| Details Issues related to manufacture, supply chain, and stockpile of anti-infective active pharmaceutical ingredients (API) and finished dosage form (FDF) |
Xellia North America
|
WINNING STRATEGIES WASHINGTON | |||
| Details H.R, 1629/S 250: Fairness in Orphan Drug Exclusivity Act |
Aquestive Therapeutics, Inc
|
RUBICON ADVISORS, LLC | |||
| Details Issues related to tele-health. Ryan Haight Act. H.R. 2617 - Consolidated Appropriations Act, 2023. Issues related to tele-health. Ryan Haight Act. Legislation related to LGBTQ issues. |
Mariposa Health, Inc. (on behalf of PLUME)
|
Mehlman Consulting, Inc. (f/k/a Mehlman Castagnetti Rosen & Thomas, Inc.) | |||
| Details Prescription drug pricing generally Pharmacy Benefit Manager (PBM) reform generally S. 2973 (Modernizing and Ensuring PBM Accountability Act), all provisions S. 1339 (Pharmacy Benefit Manager Refor... |
American Pharmacy Cooperative, Inc.
|
ArentFox Schiff LLP | |||
| Details Advocated for the continued funding of the Children's Hospitals Graduate Medical Education (CHGME) program which funds pediatric residency training at children's hospitals. Advocated for continued... |
TEXAS CHILDREN'S HOSPITAL
|
in-house lobbying | |||
| Details Working with the Administration and Congress to discuss a response to COVID-19 pandemic. |
Ocugen, Inc.
|
FTI Government Affairs |